It has been reported that levels of the retromer CSC are reduced in the brains of AD patients and knockdown of VPS35 results in increased processing of amyloid precursor protein (APP) to the pro-aggregatory neurotoxic Aβ peptide (Small et al., 2005; Muhammad et al., 2008). Here, APP is linked to Alzheimer disease.